Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Linde
LIN
|
$588M |
| 2 |
Apple
AAPL
|
$574M |
| 3 |
Illumina
ILMN
|
$398M |
| 4 |
Monster Beverage
MNST
|
$396M |
| 5 |
argenx
ARGX
|
$306M |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
$600M |
| 2 |
AbbVie
ABBV
|
$323M |
| 3 |
Sherwin-Williams
SHW
|
$309M |
| 4 |
Atlassian
TEAM
|
$250M |
| 5 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$241M |
Sector Composition
| 1 | Technology | 31.85% |
| 2 | Healthcare | 19.69% |
| 3 | Industrials | 10.43% |
| 4 | Financials | 10.02% |
| 5 | Consumer Discretionary | 9.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Ascendis Pharma
ASND
$11.8B
| $379M | 0.25% | 3,532,830 -111,125 | -3% | -$11.9M |
|
102
Walt Disney
DIS
$213B
| $378M | 0.25% | 3,773,376 +95,503 | +3% | +$9.56M |
|
103
Hershey
HSY
$37.3B
| $371M | 0.24% | 1,456,372 +14,928 | +1% | +$3.8M |
|
104
Sysco
SYY
$38.5B
| $361M | 0.24% | 4,668,479 +689,567 | +17% | +$53.3M |
|
105
Costco
COST
$418B
| $356M | 0.23% | 716,270 -6,551 | -0.9% | -$3.26M |
|
106
Synopsys
SNPS
$112B
| $351M | 0.23% | 908,133 -12,558 | -1% | -$4.85M |
|
107
Cooper Companies
COO
$13.4B
| $350M | 0.23% | 938,664 -104,801 | -10% | -$39.1M |
|
108
Edwards Lifesciences
EW
$47.8B
| $348M | 0.23% | 4,201,195 +374,517 | +10% | +$31M |
|
109
Cisco
CSCO
$274B
| $342M | 0.23% | 6,535,704 +1,485,537 | +29% | +$77.7M |
|
110
TFI International
TFII
$7.87B
| $341M | 0.22% | 2,854,710 +1,399,515 | +96% | +$167M |
|
111
ServiceNow
NOW
$190B
| $334M | 0.22% | 719,539 -18,897 | -3% | -$8.78M |
|
112
BioMarin Pharmaceuticals
BMRN
$11.2B
| $334M | 0.22% | 3,437,284 -451,160 | -12% | -$43.9M |
|
113
Novartis
NVS
$245B
| $332M | 0.22% | 3,610,783 -322,510 | -8% | -$29.7M |
|
114
Zoetis
ZTS
$69.3B
| $331M | 0.22% | 1,990,089 +202,748 | +11% | +$33.7M |
|
115
Goldman Sachs
GS
$226B
| $325M | 0.21% | 994,393 +66,355 | +7% | +$21.7M |
|
116
Prologis
PLD
$106B
| $319M | 0.21% | 2,559,549 +63,209 | +3% | +$7.88M |
|
117
O'Reilly Automotive
ORLY
$88B
| $318M | 0.21% | 374,708 -24,349 | -6% | -$20.7M |
|
118
Aramark
ARMK
$10.3B
| $316M | 0.21% | 8,833,098 +99,992 | +1% | +$3.58M |
|
|
NATI
119
DELISTED
National Instruments Corp
NATI
| $313M | 0.21% | 5,973,988 -2,911,022 | -33% | -$153M |
|
120
Apellis Pharmaceuticals
APLS
$3.48B
| $309M | 0.2% | 4,681,482 +693,737 | +17% | +$45.8M |
|
121
Dentsply Sirona
XRAY
$2.85B
| $303M | 0.2% | 7,704,667 +526,339 | +7% | +$20.7M |
|
122
Ziff Davis
ZD
$1.57B
| $300M | 0.2% | 3,848,674 -35,086 | -0.9% | -$2.74M |
|
123
CarMax
KMX
$9.21B
| $292M | 0.19% | 4,540,382 -2,126 | -0% | -$137K |
|
124
Intuit
INTU
$186B
| $289M | 0.19% | 647,183 +287,218 | +80% | +$128M |
|
125
Automatic Data Processing
ADP
$123B
| $287M | 0.19% | 1,289,799 +744,403 | +136% | +$166M |
|